Ameya Paleja

By

Testing and Tracing: Case for a Relook

The Drug Controller General of India has given emergency approvals to vaccine candidates being manufactured in India. The Government of India is also keen on a nationwide rollout through a mass vaccination campaign.  While the focus should be on ensuring...

Tracking the COVID-19 Vaccine # 2

A lot has changed since the last blog post. Pfizer, Moderna and AstraZeneca have declared preliminary results for their ongoing Phase III trials while the UK has rushed to grant approval to the Pfizer vaccine and aims to begin vaccinations...

All Things Policy: How Effective Are the New COVID Vaccines?

 How is vaccine effectiveness calculated? Should ministers be part of vaccine clinical trials? Sunila Dixit is joined by Ameya Paleja and Shambhavi Naik to discuss the latest developments in vaccines to combat COVID-19. Ask us your questions about COVID-19...

Takshashila Discussion Document – A COVID-19 Vaccine Deployment Strategy for India

Download the Discussion Document in PDF by Shambhavi Naik, Ameya Paleja, Mihir Mahajan, Narayan Ramachandran, Sunila Dixit, Rahul Matthan, Nitin Pai and Pranay Kotasthane Deploying COVID-19 vaccines once they are available is going to be an unprecedented administrative and logistical...

Tracking the COVID-19 Vaccine

Tracking the COVID-19 Vaccine By Ameya Paleja To contain the COVID-19 pandemic, India has a mammoth task of vaccinating a major share of her population. At Takshashila Institution, we recently recommended a strategy to vaccinate 80% of India’s population by...

All Things Policy: Pfizer and the Hunt for a COVID-19 Vaccine

 What does Pfizer’s announcement about its COVID-19 vaccine mean? Why did Brazil halt China’s SinoVac vaccine trial? When will Serum Institute’s vaccine be ready? Manoj Kewalramani is joined by Ameya Paleja and Sunila Dixit to talk about progress being...

A COVID-19 Vaccine Deployment Strategy for India

This paper first appeared in Indian Public Policy Review 2020, 1(2): 42 – 58 by Shambhavi Naik, Ameya Paleja, Mihir Mahajan, Narayan Ramachandran, Sunila Dixit, Rahul Matthan, Nitin Pai and Pranay Kotasthane Abstract Deploying COVID-19 vaccines once they are available is...